FIRAZYR
Report
- Report Number
- 2032282-2024-00001
- Event Type
- Malfunction
- Date Received
- February 16, 2024
- Date of Event
- February 1, 2024
- Report Date
- March 15, 2024
- Manufacturer
- TAKEDA PHARMACEUTICALS AMERICA, INC.
- Product Code
- FMF
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA
- Reporter Occupation
- NURSE
- Health Professional
- Yes
Narratives
DEVICE ISSUE CANNOT BE CONFIRMED BECAUSE SAMPLE WAS NOT RETURNED. INVESTIGATION REPORT FROM VETTER (CMO) INCLUDES, A QUERY WAS PERFORMED WITHIN THE VETTER QUALITY MANAGEMENT SYSTEM REGARDING ANY NONCONFORMITIES FOR THE AFFECTED BATCH. NO DEVIATIONS AND NO FURTHER COMPLAINTS WERE DOCUMENTED. ADDITIONALLY, THE FIRAZYR BATCHES MANUFACTURED BEFORE AND AFTER THE IMPACTED BATCH WERE INCLUDED INTO THE QUERY. BASED ON THESE RESULTS, THERE IS NO TREND INDICATED REGARDING SIMILAR COMPLAINTS FOR THE PRODUCT FIRAZYR. NO POSSIBLE ROOT CAUSE IS PRESENT DURING MANUFACTURING AT VETTER , NO CAPA WAS INITIATED. BASED ON THE RESULTS OF THE CONDUCTED INVESTIGATION, THERE IS NO IMPACT ON THE QUALITY OF THE IMPACTED BATCH. DHL (CMO) ALSO CONDUCTED INVESTIGATION, A ROOT CAUSE WAS NOT IDENTIFIED FOR THE REPORTED DEFECT. IT IS UNLIKELY THAT A DEFECT OF THIS NATURE WOULD OCCUR DURING THE PACKAGING PROCESS AT DHL. THIS IS THE ONLY COMPLAINT RECEIVED ON THIS LOT RELATED TO THIS DEFECT. NO LOT TREND HAS BEEN ESTABLISHED.
A SAMPLE HAS BEEN REQUESTED TO INVESTIGATE THE ISSUE.
PATIENT REPORTED "I HAD TO TAKE FIRAZYR EARLY THIS MORNING. I WAS ONLY ABLE TO INJECT HALF OF THE DOSE FOR SOME REASON AND THEN IT FELT LIKE THE PLUNGER WAS RESISTING."
PATIENT REPORTED "I HAD TO TAKE FIRAZYR EARLY THIS MORNING. I WAS ONLY ABLE TO INJECT HALF OF THE DOSE FOR SOME REASON AND THEN IT FELT LIKE THE PLUNGER WAS RESISTING? I HAVE NO OTHER DOSES."
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1085638 | FIRAZYR | SYRINGE, PISTON | FMF | TAKEDA PHARMACEUTICALS AMERICA, INC. | TFVJ09A15 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 23 YR | Female | TAKHZYRO |